ID   YCR-1
AC   CVCL_A397
SY   Yokohama City Renal-1
DR   Cosmic; 849377
DR   Wikidata; Q54995346
RX   PubMed=3528602;
RX   PubMed=11146448;
CC   Population: Japanese.
CC   Doubling time: 26.5 hours (PubMed=3528602).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
RX   PubMed=3528602; DOI=10.5980/jpnjurol1928.77.4_653;
RA   Masuda, Mitsunobu
RA   Sakuramoto, Toshio
RA   Moriyama, Masatoshi
RA   Miura, Takeshi
RA   Shuin, Taro
RA   Kubota, Yoshinobu
RT   "Human renal cell carcinoma: establishment of a new cell line (YCR-1)
RT   using soft agar culture technic.";
RL   Nihon Hinyokika Gakkai Zasshi 77:653-658(1986).
//
RX   PubMed=11146448; DOI=10.1002/1097-0215(200002)9999:9999<::AID-IJC1034>3.0.CO;2-S;
RA   Kondo, Kei-ichi
RA   Yao, Masahiro
RA   Kobayashi, Kazuki
RA   Ota, Shinsuke
RA   Yoshida, Minoru
RA   Kaneko, Shigeki
RA   Baba, Masaya
RA   Sakai, Naoki
RA   Kishida, Takeshi
RA   Kawakami, Satoshi
RA   Uemura, Hiroji
RA   Nagashima, Yoji
RA   Nakatani, Yukio
RA   Hosaka, Masahiko
RT   "PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and
RT   renal carcinoma cell lines.";
RL   Int. J. Cancer 91:219-224(2001).
//